Parkinson’s disease treatment recommended for restricted use within NHS Wales

Opicapone is restricted within the licensed indication for use after failure of entacapone, or in patients who cannot tolerate entacapone.

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date
Register

Existing members Sign in